Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma.

Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma.

http://www.wikidata.org/entity/Q43034794

about

New advances in hepatocellular carcinoma Hepatitis C and Innate Immunity: Recent Advances Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis Involvement of DNA damage response pathways in hepatocellular carcinoma.Gene expression in nontumoral liver tissue and recurrence-free survival in hepatitis C virus-positive hepatocellular carcinoma Targeting the inflammation in HCV-associated hepatocellular carcinoma: a role in the prevention and treatment Role of MicroRNAs in Hepatocellular Carcinoma Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine?Single nucleotide polymorphisms of microRNA processing machinery genes and outcome of hepatocellular carcinoma.Alcohol and hepatitis C virus--interactions in immune dysfunctions and liver damage.Precore/Core Region Mutations in Hepatitis B Virus DNA Predict Postoperative Survival in Hepatocellular Carcinoma.SNP rs2057482 in HIF1A gene predicts clinical outcome of aggressive hepatocellular carcinoma patients after surgery.8-Hydroxy-2'-deoxyguanosine expression predicts hepatocellular carcinoma outcome Tumor necrosis factor-alpha 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma.Meta-analysis of the correlation between selenium and incidence of hepatocellular carcinoma Mitochondrial DNA haplogroup M is associated with late onset of hepatocellular carcinoma Characteristic expression pattern of oxidative stress in livers with cryptogenic hepatocellular carcinoma Hepatic oxidative DNA damage is associated with increased risk for hepatocellular carcinoma in chronic hepatitis C.Protective effect of Juzen-taiho-to on hepatocarcinogenesis is mediated through the inhibition of Kupffer cell-induced oxidative stress Potential biomarkers of ageing.Interactions Between Hepatitis C Virus and Mitochondria: Impact on Pathogenesis and Innate Immunity.Macrophage colony-stimulating factor expressed in non-cancer tissues provides predictive powers for recurrence in hepatocellular carcinoma.Hepatocellular carcinoma in non-alcoholic steatohepatitis: Growing evidence of an epidemic?HCV and oxidative stress in the liver.Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations.Redox regulation of inflammation: old elements, a new story.Dysregulated miRNA in progression of hepatocellular carcinoma: A systematic review.Antagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma.Mutations in hepatitis B virus small S genes predict postoperative survival in hepatocellular carcinoma.Prognostic value of red blood cell distribution width in hepatocellular carcinoma.Alteration of amino acid and biogenic amine metabolism in hepatobiliary cancers: Findings from a prospective cohort study.Preoperative transcatheter arterial chemotherapy may suppress oxidative stress in hepatocellular carcinoma cells and reduce the risk of short-term relapse.Circulating Biomarkers and their Possible Role in Pathogenesis of Chronic Hepatitis B and C Viral Infections.X protein mutations in hepatitis B virus DNA predict postoperative survival in hepatocellular carcinoma.A polymorphism at the microRNA binding site in the 3' untranslated region of RYR3 is associated with outcome in hepatocellular carcinoma.HCV-related proteins activate Kupffer cells isolated from human liver tissues.Interrelationships among genetic C677T polymorphism of 5,10-methylenetetrahydrofolate reductase, biochemical folate status, and lymphocytic p53 oxidative damage in association with tumor malignancy and survivals of patients with hepatocellular carci A polymorphism at the miR-502 binding site in the 3'-untranslated region of the histone methyltransferase SET8 is associated with hepatocellular carcinoma outcome.Metabolite target analysis of human urine combined with pattern recognition techniques for the study of symptomatic gout.Hepatocellular carcinoma patients with increased oxidative stress levels are prone to recurrence after curative treatment: a prospective case series study using the d-ROM test.

P2860

Q26749329-FD699792-3268-47F8-BF90-7243BBD5EA73 Q27487394-1E4D107A-3B4A-4802-A834-6882AAD0010D Q28075646-A7AF6EC2-179A-4994-BEAD-0A80E6C28A84 Q33616812-620227E8-78EB-450E-A73D-F3AF2CB9E745 Q33797504-3F2129E7-5802-49C2-9FB2-1AC3EB8F5513 Q34347862-419EDD58-FDCE-48F4-B135-03C65E560E4E Q34348824-5185763E-DA73-4FE2-A3A7-1D08BB2041E3 Q35048768-75BFAD7D-DF22-48F8-98FC-FBF9A3B983EF Q35133706-EBEE6790-CF86-4540-BFBA-07D20B3AB665 Q35660303-AB21DCC8-731F-464A-A256-8683E0E9F21F Q35711706-9019F1A1-355F-47FA-A4B2-A4CED911C857 Q35785191-96ABCA40-DF55-4F82-BF9B-4C5737B2A1C3 Q35995355-0269B433-2C4F-4E15-851B-67D28B92299B Q36143638-CF4F011E-66F3-4CFC-B17D-AB2ED1CC3E9C Q36174323-E694DD12-765C-48EA-A5C8-0722C57C5D2C Q36224454-5C299F71-E55B-4CF3-9069-08883314759C Q36244269-78246B73-605D-4ED6-BEAE-CC5ABDF70F44 Q36459759-62E91B81-A59F-447F-BB1F-7FFC31C73150 Q36946710-9BDA1547-D71F-424F-B435-FDD700394D0C Q37061417-66D92F87-C7C7-4515-81B7-559518862A25 Q37095314-1DEA4B57-C318-465C-AAE4-5C9ABB769395 Q37359619-98A2218B-DC7D-4E43-ADAB-7FDEA88A79E4 Q37932057-0DEE310E-4010-4489-8076-D3C69E527D73 Q38077447-9D5FC17B-702D-46F7-B9B1-D72D34C65006 Q38157936-45CA08C5-6769-45E3-9CC4-32346D14B872 Q38244572-2356F3B4-81FB-4F48-85BB-87AC3B8A19B8 Q38613525-47DE2250-7978-4B44-A155-73B90523D87E Q39439263-563B75A9-8B6F-4797-8BBC-4DFF9D3AC7A6 Q40422810-30EAA79E-814B-495C-B129-5FF3A89A66CD Q41050154-7903EBC7-9418-4645-9B3B-AE5A914D1E65 Q41518664-E763644E-F001-4451-A40D-D6E556B81F2D Q41552085-FB8472A6-E329-4629-896E-9C11CA3E804B Q42128346-9C02BBDC-C827-412D-A00F-E0FCF3DCCE30 Q42205637-B9437127-6D79-4824-A5A8-B1FCA47E0594 Q42557917-C0F76FBE-520F-49B4-8562-B1155764D41A Q42999998-E70D113F-5BB8-4B85-82A4-A9232D6DD3CC Q43591529-7E02CD43-2F35-49BD-A8FD-899ABAC609AC Q43849549-8E3E6792-0D68-4D22-90B6-111395518685 Q44795321-52A83361-EA65-43DA-A4DF-99E76BF39586 Q45247507-BF2CFFEE-1263-46BE-8670-325813B00081

P2860

Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma.

http://www.wikidata.org/entity/Q43034794

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Predictive power of biomarkers ...... ated hepatocellular carcinoma.

@en

Predictive power of biomarkers ...... ated hepatocellular carcinoma.

@nl

type

label

Predictive power of biomarkers ...... ated hepatocellular carcinoma.

@en

Predictive power of biomarkers ...... ated hepatocellular carcinoma.

@nl

prefLabel

Predictive power of biomarkers ...... ated hepatocellular carcinoma.

@en

Predictive power of biomarkers ...... ated hepatocellular carcinoma.

@nl

P1433

Q43034794-90814DFC-D8AD-44DC-BA19-DE6B755451A7

P1476

Q43034794-42C6CB31-8A35-4C19-99E1-42224C3A12F2

P2093

Q43034794-19383455-00C4-4776-B65A-83C46EF12002

Q43034794-304384DD-5F88-48CC-A0D8-CB1A4541169C

Q43034794-47163ABF-C255-48C2-B146-6B95F1CC1E2C

Q43034794-55FA8D50-C331-43A0-88E1-A0FEED531204

Q43034794-661AA09D-0819-4343-9940-B4EFFBEE0760

Q43034794-6DF52D13-B17A-4B16-BAB0-4BFB6CB083CD

Q43034794-A182C2F4-9B4D-42AC-B040-F7543CE099F1

Q43034794-AA1CFF5C-105E-462C-9F8E-3ADA4DDB1E04

P2860

Q43034794-B334E222-BD17-480F-9C71-8235CD716DC5

P2888

Q43034794-C25C1EB0-24EC-42A6-8644-25C492A6DDE2

P304

Q43034794-78A8AD82-6878-47F4-850B-A9687F2085FC

P31

Q43034794-A2A64665-1CD4-4E29-8C01-0306C2FEA851

P356

Q43034794-2F03B11D-69C3-4259-B9E7-80983A6921AA

P433

Q43034794-2629D80A-9B4D-43D9-BE42-974A9C9D8F1F

P478

Q43034794-356F9272-37E8-4A4D-A48B-2AB34C8054B7

P577

Q43034794-D67A8B14-3A25-4090-8A0B-B5024E7D2B05

P5875

Q43034794-B230080F-7BE0-49C6-861A-A937E8946ADA

P6179

Q43034794-328C8D3B-1B51-4912-B215-21223498B301

P698

Q43034794-C1F877DD-9023-4DBE-9D89-E76C137CEE11

P921

Q43034794-50EAE81F-9623-465F-BD7F-BF6A73F90E7E

P356

S10434-006-9049-1

P1433

Annals of Surgical Oncology

P1476

Predictive power of biomarkers ...... ated hepatocellular carcinoma.

@en

P2093

Akira Maki

http://www.w3.org/2001/XMLSchema#string

Hideki Fujii

http://www.w3.org/2001/XMLSchema#string

Hiroshi Kono

http://www.w3.org/2001/XMLSchema#string

Ivan Rusyn

http://www.w3.org/2001/XMLSchema#string

Masami Asakawa

http://www.w3.org/2001/XMLSchema#string

Masanori Matsuda

http://www.w3.org/2001/XMLSchema#string

Mayetri Gupta

http://www.w3.org/2001/XMLSchema#string

Tetsuya Suzuki

http://www.w3.org/2001/XMLSchema#string

P2860

Promotion of rat hepatocarcinogenesis by dimethylarsinic acid: association with elevated ornithine decarboxylase activity and formation of 8-hydroxydeoxyguanosine in the liver.

P2888

s10434-006-9049-1

P304

1182-1190

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-006-9049-1

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2007-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6604728

http://www.w3.org/2001/XMLSchema#string

P6179

1046212581

http://www.w3.org/2001/XMLSchema#string

P698

17195915

http://www.w3.org/2001/XMLSchema#string

P921